Clinical positron emission tomography/magnetic resonance imaging applications

Seminars in Nuclear Medicine

Volumn 43, Issue 1, 2013, Pages 3-10

  Von Schulthess, Gustav K ^a   Kuhn, Felix Pierre ^a   Kaufmann, Philipp ^a   Veit Haibach, Patrick ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLURPIRIDAZ F 18; GADOLINIUM;

ALZHEIMER DISEASE; ANGIOGENESIS; ARTICLE; CARDIAC IMAGING; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CLINICAL STUDY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROENCEPHALOGRAM; EPILEPSY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GAMMA RADIATION; HEART FUNCTION; HEART MUSCLE FIBROSIS; HUMAN; IMAGE ANALYSIS; INFORMATION PROCESSING; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; ONCOLOGY; OXYGEN CONSUMPTION; OXYGENATION; PARKINSON DISEASE; PHASE 3 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THROMBUS; WHOLE BODY IMAGING; WORKFLOW;

EID: 84870045420     PISSN: 00012998     EISSN: 15584623     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2012.08.005     Document Type: Review

References (32)

1. Y. Shao, S.R. Cherry, K. Farahani Simultaneous PET and MR imaging Phys Med Biol 42 1997 1965 1970
2. M. Hofmann, I. Bezrukov, F. Mantlik MRI-based attenuation correction for whole-body PET/MRI: Quantitative evaluation of segmentation- and atlas-based methods J Nucl Med 52 2011 1392 1399
3. A. Martinez-Möller, M. Souvatzoglou, G. Delso Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: Evaluation with PET/CT data J Nucl Med 50 2009 520 526
4. M. Hofmann, F. Steinke, V. Scheel MRI-based attenuation correction for PET/MRI: A novel approach combining pattern recognition and atlas registration J Nucl Med 49 2008 1875 1883
5. T.F. Hany, H.C. Steinert, G.W. Goerres PET diagnostic accuracy: Improvement with in-line PET-CT system: Initial results Radiology 225 2002 575 581
6. G.K. Von Schulthess, T.F. Hany Imaging and PET-PET/CT imaging J Radiol 89 2008 438 447 quiz 48
7. D.E. Maziak, G.E. Darling, R.I. Inculet Positron emission tomography in staging early lung cancer: A randomized trial Ann Intern Med 151 2009 221 228 W-48
8. S. Ben-Haim, P. Ell 18F-FDG PET and PET/CT in the evaluation of cancer treatment response J Nucl Med 50 2009 88 99
9. G.K. von Schulthess, C. Burger Integrating imaging modalities: What makes sense from a workflow perspective? Eur J Nucl Med Mol Imaging 37 2010 980 990
10. A. Samarin, C. Burger, S.D. Wollenweber PET/MR imaging of bone lesions - Implications for PET quantification from imperfect attenuation correction Eur J Nucl Med Mol Imaging 39 2012 1154 1160
11. V. Keereman, Y. Fierens, T. Broux MRI-based attenuation correction for PET/MRI using ultrashort echo time sequences J Nucl Med 51 2010 812 818
12. C. Catana, A. van der Kouwe, T. Benner Toward implementing an MRI-based PET attenuation-correction method for neurologic studies on the MR-PET brain prototype J Nucl Med 51 2010 1431 1438
13. M.C. Niekel, S. Bipat, J. Stoker Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: A meta-analysis of prospective studies including patients who have not previously undergone treatment Radiology 257 2010 674 684
14. Y. Assiri, D. Schmid, C. Pietsch Contrast-enhanced PET/CT vs. non-contrast enhanced PET/MRI in abdominal oncological lesions - Initial results Annual Congress of the European Association of Nuclear Medicine, Milan, Italy 2012
15. D.W. Crook, C. Mader, F.P. Kuhn Diagnostic performance of PET/MR versus PET/CT in the abdomen Presented at: European Congress of Radiology, Vienna 2012
16. J.N. Talbot, L. Fartoux, S. Balogova Detection of hepatocellular carcinoma with PET/CT: A prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease J Nucl Med 51 2010 1699 1706
17. R. Hustinx, G. Lucignani PET/CT in head and neck cancer: An update Eur J Nucl Med Mol Imaging 37 2010 645 651
18. H.M. van Ufford, T.C. Kwee, F.J. Beek Newly diagnosed lymphoma: Initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT Am J Roentgenol 196 2011 662 669
19. N.F. Schwenzer, C. Schraml, M. Müller Pulmonary lesion assessment: Comparison of whole-body hybrid MR/PET and PET/CT imaging - Pilot study Radiology 264 2012 551 558
20. NCCN Clinical Practice Guidelines in Oncology http://www.nccn.org/ professionals/physician-gls/f-guidelines.asp NCCN 2012 Accessed October 12
21. M.C. Asselin, J.P. O'Connor, R. Boellaard Quantifying heterogeneity in human tumours using MRI and PET Eur J Cancer 48 2012 447 455
22. J.P. O'Connor, A. Jackson, M.C. Asselin Quantitative imaging biomarkers in the clinical development of targeted therapeutics: Current and future perspectives Lancet Oncol 9 2008 766 776
23. R. Ossenkoppele, N. Tolboom, J.C. Foster-Dingley Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET Eur J Nucl Med Mol Imaging 39 2012 990 1000
24. E.R. Kenny, A.M. Blamire, M.J. Firbank Functional connectivity in cortical regions in dementia with Lewy bodies and Alzheimer's disease Brain 135 2012 569 581
25. L.K. Teune, A.L. Bartels, B.M. de Jong Typical cerebral metabolic patterns in neurodegenerative brain diseases Mov Disord 25 2010 2395 2404
26. J. Duncan The current status of neuroimaging for epilepsy Curr Opin Neurol 22 2009 179 184
27. M. Yu, S.G. Nekolla, M. Schwaiger The next generation of cardiac positron emission tomography imaging agents: Discovery of flurpiridaz F-18 for detection of coronary disease Semin Nucl Med 41 2011 305 313
28. R.S. Beanlands, G. Nichol, E. Huszti F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: A randomized, controlled trial (PARR-2) J Am Coll Cardiol 50 2007 2002 2012
29. R.O. Bonow, G. Maurer, K.L. Lee Myocardial viability and survival in ischemic left ventricular dysfunction N Engl J Med 364 2011 1617 1625
30. L. Cortigiani, R. Bigi, R. Sicari Is viability still viable after the STICH trial? Eur Heart J Cardiovasc Imaging 13 2012 219 226
31. A.P. Pazhenkottil, R.N. Nkoulou, J.R. Ghadri Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography Eur Heart J 32 2011 1465 1471
32. A.P. Pazhenkottil, R.N. Nkoulou, J.R. Ghadri Impact of cardiac hybrid single-photon emission computed tomography/computed tomography imaging on choice of treatment strategy in coronary artery disease Eur Heart J 32 2011 2824 2829